RHHBY It's not just about the numbers for me; it's about the potential impact and long-term growth prospects. This gem not only promises solid returns but also contributes to healthcare advancements in Switzerland. My conservative estimate? $38 USD, but I'm aiming for the stars at $58 USD per share. Of course, every investment comes with its risks, so it's crucial to assess your own risk tolerance and do your due diligence. Here's to growth and making a positive difference!